Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.33M | 86.31M | 88.85M | 89.58M | 91.01M |
| Total Other Revenue | -- | -- | -- | -- | 921.00K |
| Total Revenue | 85.33M | 86.31M | 88.85M | 89.58M | 91.01M |
| Cost of Revenue | 53.63M | 54.64M | 54.53M | 56.78M | 60.33M |
| Gross Profit | 31.70M | 31.68M | 34.32M | 32.80M | 30.67M |
| SG&A Expenses | 109.86M | 111.84M | 109.71M | 106.47M | 103.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 178.64M | 180.70M | 179.04M | 177.80M | 178.02M |
| Operating Income | -93.31M | -94.38M | -90.19M | -88.23M | -87.01M |
| Income Before Tax | -96.70M | -101.57M | -90.47M | -97.60M | -90.40M |
| Income Tax Expenses | -37.88M | -1.67M | -338.00K | 310.00K | 542.00K |
| Earnings from Continuing Operations | -58.83 | -99.90 | -90.14 | -97.91 | -90.94 |
| Earnings from Discontinued Operations | -16.07M | -28.35M | -30.37M | -34.86M | -47.95M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.90M | -128.25M | -120.50M | -132.76M | -138.89M |
| EBIT | -93.31M | -94.38M | -90.19M | -88.23M | -87.01M |
| EBITDA | -78.26M | -72.13M | -63.17M | -60.79M | -58.55M |
| EPS Basic | -0.20 | -0.34 | -0.32 | -0.36 | -0.55 |
| Normalized Basic EPS | -0.13 | -0.14 | -0.13 | -0.13 | -0.13 |
| EPS Diluted | -0.20 | -0.34 | -0.32 | -0.36 | -0.55 |
| Normalized Diluted EPS | -0.13 | -0.14 | -0.13 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 1.53B | 1.52B | 1.50B | 1.50B | 1.41B |
| Average Diluted Shares Outstanding | 1.53B | 1.52B | 1.50B | 1.50B | 1.41B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |